Madrigal Pharmaceuticals Market Sentiment

Madrigal Pharmaceuticals Inc

MDGLNASDAQ

$434.24

-19.10-4.21%

Últ. Act.: Oct 23, 4:00 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivo FinanzasSentimientoPropiedad Comparar Opciones Informe de acciones

Ganancias: Beneficios de Q3 2026 dentro de 11 días de ahora en mar nov 3rd, antes de la apertura del mercado

Madrigal Pharmaceuticals Market Sentiment - Benzinga

Madrigal Pharmaceuticals Market Sentiment

Market sentiment signals for Madrigal Pharmaceuticals (MDGL): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 12.2% short float

Options Flow▲ 0.23 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

22 analysts

Options Flow (P/C)

0.23

More calls — Bullish

115 calls · 27 puts

Avg Consensus PT

$625

+44.0%

Highest Price Target

$962

+121.5%

Barclays

Lowest Price Target

$382

-12.0%

Citigroup

Short Interest

12.2%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 24, 2026	Goldman Sachs	Andrea Newkirk—	+62.1%	$704	Reinstates	Buy
Sep 23, 2026	Citigroup	Eric Joseph—	+67.0%	$725	Initiate	Buy
Aug 4, 2026	Wolfe Research	Andy Chen—	+39.3%	$605	Upgrade	Peer Perform→Outperform
Aug 3, 2026	Barclays	Eliana Merle—	+121.5%	$964 → $962	Maintained	Overweight
Jul 29, 2026	Canaccord Genuity	Edward Nash—	+35.2%	$578 → $587	Maintained	Buy
Jul 27, 2026	Wells Fargo	Sadia Rahman—	+57.7%	$685	Initiate	Overweight
Jun 11, 2026	B of A Securities	Alexandria Hammond—	+24.8%	$550 → $542	Maintained	Neutral
May 13, 2026	Truist Securities	Srikripa Devarakonda—	+63.3%	$640 → $709	Maintained	Buy
May 7, 2026	Canaccord Genuity	Edward Nash—	+33.1%	$587 → $578	Maintained	Buy
May 7, 2026	Evercore ISI Group	Liisa Bayko—	+49.5%	$652 → $649	Maintained	Outperform
May 6, 2026	HC Wainwright & Co.	Andrew S. Fein—	+42.8%	$620 → $620	Maintained	Buy
Feb 20, 2026	B of A Securities	Alexandria Hammond—	+21.8%	$570 → $529	Maintained	Neutral
Jan 28, 2026	Barclays	Eliana Merle—	+122.0%	$964	Initiate	Overweight
Jan 20, 2026	Citizens	Jonathan Wolleben—	+71.6%	$527 → $745	Maintained	Market Outperform
Dec 19, 2025	Piper Sandler	Yasmeen Rahimi—	+107.3%	$540 → $900	Maintained	Overweight
Dec 11, 2025	B. Riley Securities	William Woods—	+54.3%	$560 → $670	Maintained	Buy
Nov 21, 2025	HC Wainwright & Co.	Andrew S. Fein—	+42.8%	$568 → $620	Maintained	Buy
Nov 20, 2025	Oppenheimer	Jay Olson—	+49.7%	$600 → $650	Maintained	Outperform
Nov 19, 2025	Truist Securities	Srikripa Devarakonda—	+47.4%	$580 → $640	Maintained	Buy
Nov 13, 2025	Canaccord Genuity	Edward Nash—	+35.2%	$526 → $587	Maintained	Buy
Nov 11, 2025	HC Wainwright & Co.	Andrew S. Fein—	+30.8%	$500 → $568	Maintained	Buy
Nov 5, 2025	Cantor Fitzgerald	Prakhar Agrawal—	—	—	Upgrade	Neutral→Overweight
Nov 5, 2025	Citizens	Jonathan Wolleben—	+21.4%	$485 → $527	Maintained	Market Outperform
Nov 3, 2025	B of A Securities	Alexandria Hammond—	+2.5%	$266 → $445	Upgrade	Underperform→Neutral
Oct 15, 2025	Piper Sandler	Yasmeen Rahimi—	+24.4%	$400 → $540	Maintained	Overweight